Biotech Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program January 6, 2025
Biotech Optimizing Outsourcing: A Case Study on Evaluating CDMO Capabilities for API and FD Development January 3, 2025
Biotech Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers January 2, 2025
Biotech IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors December 30, 2024
Biotech Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock December 29, 2024
Biotech Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing December 27, 2024
Biotech Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS December 26, 2024
Search
Biotech
January 6, 2025
January 3, 2025
January 2, 2025
January 1, 2025
December 31, 2024
December 30, 2024
December 29, 2024
December 28, 2024
December 27, 2024
December 26, 2024
